An in situ cross-linking hybrid hydrogel for controlled release of proteins
- 1 May 2012
- journal article
- Published by Elsevier in Acta Biomaterialia
- Vol. 8 (5) , 1703-1709
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Deafness and Other Communication Disorders (R21 DC 009986)
This publication has 24 references indexed in Scilit:
- A microcomposite hydrogel for repeated on-demand ultrasound-triggered drug deliveryBiomaterials, 2010
- Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2Acta Biomaterialia, 2008
- Polymers in the prevention of peritoneal adhesionsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2008
- Peritoneal adhesion prevention with an in situ cross-linkable hyaluronan gel containing tissue-type plasminogen activator in a rabbit repeated-injury modelBiomaterials, 2007
- Prevention of peritoneal adhesions with an in situ cross-linkable hyaluronan hydrogel delivering budesonideJournal of Controlled Release, 2007
- In Situ Cross-linkable Hyaluronan Hydrogels Containing Polymeric Nanoparticles for Preventing Postsurgical AdhesionsAnnals of Surgery, 2007
- In situ cross-linkable hyaluronic acid hydrogels prevent post-operative abdominal adhesions in a rabbit modelBiomaterials, 2006
- Collagen composite hydrogels for vocal fold lamina propria restorationBiomaterials, 2006
- Development and validation of a bioassay for Interleukin-2Journal of Pharmaceutical and Biomedical Analysis, 1992
- Administration of IL-2-PE40 via osmotic pumps prevents adjuvant induced arthritis in rats. Improved therapeutic index of IL-2-PE40 administered by continuous infusionInternational Journal of Immunopharmacology, 1991